Interleukin-6 CpG Methylation and Body Weight Correlate Differently in Type 2 Diabetes Patients Compared to Obese and Lean Controls

Journal of Nutrigenetics and Nutrigenomics

Volumn 8, Issue 1, 2015, Pages 26-35

  Aumueller, Eva ^a   Remely, Marlene ^a   Baeck, Hanna ^a   Hippe, Berit ^a   Brath, Helmut ^b   Haslberger, Alexander G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Health Centre South   (Austria)

Author keywords

Adiposity; CpG methylation; Diabetes mellitus type 2; Epigenetics; Inflammation; Interleukin 6; Metabolic syndrome

Indexed keywords

INTERLEUKIN 6; LIRAGLUTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EXON; FEMALE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; AGED; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; BODY WEIGHT; CASE-CONTROL STUDIES; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 84930914005     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000381714     Document Type: Article

References (38)

1. International Diabetes Federation: IDF Diabetes Atlas, ed 6. Brussels, IDF, 2013.
2. Remely M, Aumueller E, Jahn D, Hippe B, Brath H, Haslberger AG: Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef Microbes 2014; 5: 33-43.
3. Remely M, Aumueller E, Merold C, Dworzak S, Hippe B, Zanner J, Pointner A, Brath H, Haslberger AG: Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 2014; 537: 85-92.
4. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-1487.
5. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G: The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477-1482.
6. Voight BF, Scott LJ, Steinthorsdottir V, et al; MAGIC Investigators; GIANT Consortium: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42: 579-589.
7. Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
8. Tang L, Ye H, Hong Q, Wang L, Wang Q, Wang H, Xu L, Bu S, Zhang L, Cheng J, Liu P, Le Y, Ye M, Mai Y, Duan S: Elevated CpG island methylation of GCK gene predicts the risk of type 2 diabetes in Chinese males. Gene 2014; 547: 329-333.
9. Canivell S, Ruano EG, Siso-Almirall A, Kostov B, Gonzalez-de Paz L, Fernandez-Rebollo E, Hanzu FA, Parrizas M, Novials A, Gomis R: Differential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naïve patients with type 2 diabetes. PLoS One 2014; 9:e99310.
10. Kuehnen P, Mischke M, Wiegand S, Sers C, Horsthemke B, Lau S, Keil T, Lee YA, Grueters A, Krude H: An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet 2012; 8:e1002543.
11. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, Wainstein J, Friedlander Y, Levy-Lahad E, Glaser B, Hellman A: Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012; 21: 371-383.
12. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N: Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014; 105: 141-150.
13. Bruun JM, Helge JW, Richelsen B, Stallknecht B: Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006; 290:E961-E967.
14. Belalcazar LM, Haffner SM, Lang W, Hoogeveen RC, Rushing J, Schwenke DC, Tracy RP, Pi-Sunyer FX, Kriska AM, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group: Lifestyle intervention and/ or statins for the reduction of C-reactive protein in type 2 diabetes: from the Look AHEAD study. Obesity (Silver Spring) 2013; 21: 944-950.
15. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
16. O'Rourke RW, White AE, Metcalf MD, Olivas AS, Mitra P, Larison WG, Cheang EC, Varlamov O, Corless CL, Roberts CT Jr, Marks DL: Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 2011; 54: 1480-1490.
17. Skurk T, Alberti-Huber C, Herder C, Hauner H: Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
18. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R: CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
19. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320.
20. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
21. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
22. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF: Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 2002; 277: 1531-1537.
23. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003; 88: 3005-3010.
24. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E: SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 2000; 275: 15985-15991.
25. Poplutz MK, Wessels I, Rink L, Uciechowski P: Regulation of the interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. Immunobiology 2014; 219: 619-626.
26. Dandrea M, Donadelli M, Costanzo C, Scarpa A, Palmieri M: MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res 2009; 37: 6681-6690.
27. Cho YM, Wideman RD, Kieffer TJ: Clinical application of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus. Endocrinol Metab (Seoul) 2013; 28: 262-274.
28. Vilsboll T, Agerso H, Krarup T, Holst JJ: Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab 2003; 88: 220-224.
29. Holst JJ: On the physiology of GIP and GLP-1. Horm Metab Res 2004; 36: 747-754.
30. De Marinis YZ, Salehi A, Ward CE, Zhang Q, Abdulkader F, Bengtsson M, Braha O, Braun M, Ramracheya R, Amisten S, Habib AM, Moritoh Y, Zhang E, Reimann F, Rosengren AH, Shibasaki T, Gribble F, Renstrom E, Seino S, Eliasson L, Rorsman P: GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N-and L-type Ca 2+ channel-dependent exocytosis. Cell Metab 2010; 11: 543-553.
31. Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C: Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. J Clin Endocrinol Metab 2006; 91: 1916-1923.
32. Thaler R, Karlic H, Rust P, Haslberger AG: Epigenetic regulation of human buccal mucosa mitochondrial superoxide dismutase gene expression by diet. Br J Nutr 2009; 101: 743-749.
33. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A: White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012; 7: 606-614.
34. Gonzalo S: Epigenetic alterations in aging. J Appl Physiol 2010; 109: 586-597.
35. Vanyushin BF, Nemirovsky LE, Klimenko VV, Vasiliev VK, Belozersky AN: The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents. Gerontologia 1973; 19: 138-152.
36. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC: Feeding pregnant rats a proteinrestricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 2008; 100: 278-282.
37. Campion J, Milagro FI, Goyenechea E, Martinez A: TNF promoter methylation as a predictive biomarker for weight-loss response. Obesity 2009; 17: 1293-1297.
38. Gudmundsson A, Ershler WB, Goodman B, Lent SJ, Barczi S, Carnes M: Serum concentrations of interleukin-6 are increased when sampled through an indwelling venous catheter. Clin Chem 1997; 43: 2199-2201.